Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheets

v3.24.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2023
Dec. 31, 2022
Assets    
Cash and cash equivalents $ 9,397 $ 13,213
Accounts receivable, net 25,304 22,433
Non-trade receivable 961 2,269
Inventory 6,517 3,910
Prepaid expenses and other current assets 1,608 1,807
Total current assets 43,787 43,632
Property and equipment, net 71 168
Right-of-use assets 55 66
Contract fulfillment assets 9,232 6,848
Other assets 2,898 2,972
Total assets 56,043 53,686
Liabilities and stockholders’ equity    
Current portion of long-term debt 147
Accounts payable 19,847 21,126
Accrued liabilities 12,233 10,692
Current portion of lease liability 55 66
Deferred revenue 12 31
Total current liabilities 32,147 32,062
Income tax payable 1,528 1,429
Accrued severance 150
Total liabilities 33,675 33,641
Commitments and contingencies (Note 12)
Stockholders’ equity    
Common stock, $0.001 par value per share; 100,000,000 shares authorized: and 43,081,083 and 40,774,687 shares issued and outstanding at December 31, 2023 and 2022, respectively 43 41
Preferred stock, $0.001 par value per share, 5,000,000 shares authorized: and no shares issued and outstanding at December 31, 2023 and 2022, respectively
Additional paid-in capital 272,285 269,874
Accumulated deficit (249,960) (249,870)
Total stockholders’ equity 22,368 20,045
Total liabilities and stockholders’ equity $ 56,043 $ 53,686